期刊文献+

外周血人β-防御素2在下呼吸道感染患者的急、慢性气道炎症中的临床研究 被引量:4

原文传递
导出
摘要 目的评价外周血中人β-防御素2(hBD-2)在下呼吸道感染患者急、慢性气道炎症的临床价值。方法选取2007年3月至2008年10月下呼吸道感染患者92例,其中下呼吸道感染患者分别包括社区获得性肺炎40例,慢性阻塞性肺疾病急性加重36例,支气管扩张合并感染(急性期)16例,门诊体检者20例作为对照组,所有下呼吸道感染患者和对照组均留取血浆标本,采用酶联免疫吸附试验法检测下呼吸道感染各疾病组和对照组外周血中hBD-2、白介素1p(IL-1β)和IL-8的浓度。结果下呼吸道感染患者外周血中hBD-2、IL-1β均明显高于对照组(1P值分别为0.047、0.020);社区获得性肺炎组外周血中hBD-2浓度高于对照组(P=0.026),支气管扩张合并感染(急性期)和慢性阻塞性肺疾病急性加重组外周血中hBD-2与对照组比较差异无统计学意义(P值分别为0.334、0.227).外周血中hBD-2与炎性因子IL-1β呈正相关(r=0.280,P=0.01)。结论外周血中hBD-2可以较好反映下呼吸道感染疾病中的急性气道炎症状态,可能是气道局部炎性状态的标记物。Clinicalstudyofhumanbeta—defensin-2inpalsmaofpatientswithlowerrespiratorytractinfectionHELi—rong,HEZheng—yi,LIUSong.DepartmentoyRespiratoryMedicine,BeijingFriendshipHospitalaffiliatedtoCapitalMedicalUniversity,Beijing100050,ChinaCorrespondingauthor:LIUSong,Email:liusongyy@yahoo.COrn.m[Abstract]ObjectiveToevaluatetheclinicalvalueofplasmahumanbeta—defensin-2(hBD-2)inpatientswithlowerrespiratorytractinfection.MethodsNinety—twopatientswithlowerrespiratorytractinfectionincludedfortycasesofcommunityacquiredpneumonia,thirtysixcasesofacuteexacerbationofchronicobstructivepulmonarydisease,sixteencasesofbronchiectasis.Twentypeopleofphysicalexaminationwerecollectedascontrols.PlasmawascollectedandtheconcentrationsofhBD^2,interleukin-1/3(IL一1e)andIL一8intheplasmaweremeasuredbyenzymelinkedimmunosorbentassay.ResultsTheconcentrationsofhBD-2andII.一1口inplasmaofpatientswithlowerrespiratorytractinfectionwerehigherthanthoseofcontrols(P一0.047,P一0.020).TheconcentrationofhBD-2inplasmaofpatientswithcommunityacquiredpneumoniawashigherthanthatofcontrols(P=0.026).TherewasnostatisticaldifferenceontheconcentrationofhBD-2betweenpatientswithbronchiectasisandpatientswithacuteexacerbationofchronicobstructivepulmonarydisease(P一0.227,P一0.334).PlasmahBD-2waspositivelycorrelatedwithIL-18(r一0.280,P:0.01).ConclusionsPlasmahBD-2canindicatetheacuteinflammationstateinthelowerrespiratorytractinfection.Itmaybethemarkeroflocaltractinfection.[Keywords]Humanbet^defensin-2;Lowerrespiratorytractinfection;Communityacquiredpneumonia;
出处 《国际呼吸杂志》 2010年第8期467-471,共5页 International Journal of Respiration
  • 相关文献

参考文献13

  • 1Woodhead M.Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3057
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 4Harder J,Bartels J,Christophers E,et al.A peptide antibiotic from human skin.Nature,1997,387:861.
  • 5Hiratsuka T,Mukae H,Iiboshi H,et al.Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panhronchiolitis.Thorax,2003,58:425-430.
  • 6Hiratsuka T,Nakazato M,Date Y,et al.Identification of human beta-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia.Biochem Biophys Res Commun,1998,249:943-947.
  • 7熊盛道,兰芬,许淑云,周世新.人β-防御素-2在慢性阻塞性肺疾病患者诱导痰中的表达[J].中国现代医学杂志,2006,16(20):3069-3072. 被引量:7
  • 8王卓,姚婉贞,夏国光.慢性阻塞性肺部疾病患者血清及痰中β-防御素-2水平及临床意义[J].北京医学,2008,30(10):577-581. 被引量:6
  • 9Daulethaev N,Gropp R,Frye M,et al.Expression of human beta defensin(HBD-1 and HBD-2)mRNA in nasal epithelia of adult cystic fibrosis patients,healthy individuals,and individuals with acute cold.Respiration,2002,69:46-51.
  • 10Yanagi S,Ashitani J,Imai K,et al.Significance of human beta-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections.Clin Microbiol Infect,2007,13:63-69.

二级参考文献60

共引文献11252

同被引文献43

  • 1胡瑞成,徐永健,张珍祥,倪望,陈仕新.Correlation of HDEFB1 polymorphism and susceptibility to chronic obstructive pulmonary disease in Chinese Han population[J].Chinese Medical Journal,2004(11):1637-1641. 被引量:7
  • 2熊盛道,兰芬,许淑云,周世新.人β-防御素-2在慢性阻塞性肺疾病患者诱导痰中的表达[J].中国现代医学杂志,2006,16(20):3069-3072. 被引量:7
  • 3Guani GE,Santos MT,Lugo RSO,et al.Antimicrobial peptides:general overview and clinical implications in human health and disease[J].Clin Immunol,2010,135(1):1-11.
  • 4Chen H,Xu Z,Peng L,et al.Recent advances in the research and development of human defensins[J].Peptides,2006,27(4):931-940.
  • 5Niyonsaba F,Iwabuchi K,Matsuda H,et al.Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway[J].Int Immunol,2002,14(4):421-426.
  • 6Niyonsaba F,Ushio H,Nakano N,et al.Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration,proliferation and production of proinflammatory cytokines and chemokines[J].J Invest Dermatol,2007,127(3):594-604.
  • 7Biragyn A,Ruffini PA,Leifer CA,et al.Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2[J].Science,2002,298(5595):1025-1029.
  • 8Hiratsuka T,Nakazato M,Date Y,et al.Identification of human beta-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia[J].Biochem Biophys Res Commun,1998,249(3):943-947.
  • 9Liu S,He LR,Wang W,et al.Prognostic value of plasma human beta-defensin 2 level on short-term clinical outcomes in patients with community-acquired pneumonia:a preliminary study[J].Respiratory Care,2013,58(4):655-661.
  • 10Leow L,Simpson T,Cursons R,et al.Innate immunity and outcomes in community acquired pneumonia[J].Respirology,2011,16(4):611-616.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部